🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.780
-0.090 (-1.85%)
At close: Nov 18, 2026, 4:00 PM EST
4.827
+0.047 (0.99%)
After-hours: Nov 18, 2026, 6:46 PM EST

Ironwood Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
86.38215.4688.5692.15656.2620.13
Cash & Short-Term Investments
86.38215.4688.5692.15656.2620.13
Cash Growth
-38.48%143.29%-3.90%-85.96%5.82%71.04%
Accounts Receivable
132.7246.7581.89129.12115.46114.04
Receivables
132.7246.7581.89129.12115.46114.04
Prepaid Expenses
6.911.9811.9212.017.728.69
Restricted Cash
----1.251.25
Other Current Assets
-----1.12
Total Current Assets
225.99274.18182.37233.29780.63745.23
Property, Plant & Equipment
10.6412.7515.5218.1720.3122.93
Other Intangible Assets
1.432.042.863.68--
Long-Term Deferred Tax Assets
48.94103.43144.23212.32283.66333.29
Long-Term Deferred Charges
2.22.93.92.4--
Other Long-Term Assets
1.41.62.021.2115.9225.48
Total Assets
290.59396.9350.91471.071,1011,127

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.622.92.137.830.480.94
Accrued Expenses
17.7619.182647.2217.7133.29
Current Portion of Long-Term Debt
-199.68-199.56-116.86
Current Portion of Leases
3.33.253.193.133.073.13
Current Income Taxes Payable
1.390.930.521.240.66-
Current Unearned Revenue
1.261.112.032.62--
Other Current Liabilities
7.4115.184.9814.53.617.49
Total Current Liabilities
34.73242.2238.85276.125.53161.7
Long-Term Debt
325385583.99498.31396.25337.33
Long-Term Leases
7.919.8712.314.5416.618.48
Long-Term Unearned Revenue
3.95.3----
Other Long-Term Liabilities
16.2416.3517.1128.429.773.5
Total Liabilities
387.79658.74652.24817.37448.14521.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.170.160.160.160.150.16
Additional Paid-In Capital
1,4241,4131,3951,3551,3491,543
Retained Earnings
-1,522-1,674-1,698-1,699-696.38-937.61
Comprehensive Income & Other
0.2-1.060.92-3.03--
Shareholders' Equity
-97.19-261.84-301.34-346.3652.38605.91
Total Liabilities & Equity
290.59396.9350.91471.071,1011,127

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
336.21597.8599.48715.54415.92475.8
Net Cash (Debt)
-249.83-382.35-510.92-623.38240.29144.33
Net Cash Growth
----66.49%-
Net Cash Per Share
-1.53-2.35-3.19-4.011.290.88
Filing Date Shares Outstanding
165.55163.06161.81156.53154.16159.22
Total Common Shares Outstanding
165.55163.06160.21156.35154.03162.04
Working Capital
191.2631.96143.52-42.81755.1583.53
Book Value Per Share
-0.59-1.61-1.88-2.214.243.74
Tangible Book Value
-98.62-263.88-304.2-349.98652.38605.91
Tangible Book Value Per Share
-0.60-1.62-1.90-2.244.243.74
Machinery
-3.763.895.424.234.13
Leasehold Improvements
-7.447.417.417.417.41
SEC Filings: 10-K · 10-Q